Unlocking the Next Wave of Progress in Immunotherapy: Merck VP on the Promise of Combination Therapies

Published Jun 21, 2023

Unlocking the Next Wave of Progress in Immunotherapy: Merck VP on the Promise of Combination Therapies

×
NOW
PLAYING
Practice-Changing Research Shows Imfinzi, a Type of Immunotherapy, Significantly Increases Survival for Certain Small Cell Lung Cancers
NOW
PLAYING
Progress Treating Lung Cancer With ALK-Positive Mutations - The Drug Lorlatinib Shows Major Benefit For Progression Free Survival
NOW
PLAYING
Practice-Changing Research Indicates Tagrisso Significantly Slows Progression for EGFR-Mutated Stage 3 Lung Cancer
NOW
PLAYING
The Drug Tevimbra Now Approved For Use in Esophageal Cancer - Finally Some Help For Patients In Great Need
NOW
PLAYING
The Drug Anktiva Plus BCG for Early-Stage Bladder Cancer Treatment Offers A Good Non-Surgical Option
NOW
PLAYING
Immunotherapy for Advanced Endometrial Cancer — What are the Side Effects?

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... lung cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.